A fully liquid DTPw-HepB-Hib combination vaccine for booster vaccination of toddlers in El Salvador

Revista Panamericana de Salud Publica/Pan American Journal of Public Health

Volumn 27, Issue 2, 2010, Pages 117-124

  Suárez, Eduardo ^a   Asturias, Edwin J ^b,c   Hilbert, Anne Katrin ^d   Herzog, Christian ^e   Aeberhard, Ursula ^e   Spyr, Christian ^e  

^a University of El Salvador   (El Salvador)

^b JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^c UNIVERSIDAD DEL VALLE DE GUATEMALA   (Guatemala)

^d Novartis Vaccines and Diagnostics   (Germany)

^e CRUCELL HOLLAND BV   (Netherlands)

Author keywords

Diphtheria tetanus pertussis vaccine; El salvador; Haemophilus vaccines; Hepatitis B vaccines; Immunization; Infant; Methods; Vaccines

Indexed keywords

ANTIGEN; CHILD HEALTH; HEPATITIS; IMMUNIZATION; INFLUENZA; SAMPLE PREPARATION; THRESHOLD; VACCINATION;

BAHAMAS; EL SALVADOR [CENTRAL AMERICA]; SAN SALVADOR [BAHAMAS];

HAEMOPHILUS; HAEMOPHILUS INFLUENZAE SEROTYPE B;

EID: 77950158258     PISSN: 10204989     EISSN: 16805348     Source Type: Journal    
DOI: 10.1590/S1020-49892010000200005     Document Type: Article

References (26)

1. World Health Organization, United Nations Children's Fund. Global Immunization Vision and Strategy 2006-2015. Switzerland: WHO; 2005.
2. World Health Organization. Pertussis vaccines. WHO position paper. Wkly Epidemiol Rec. 2005;80(4):31-39
3. Halsey N, Galazka A. The efficacy of DPT and oral poliomyelitis immunization schedules initiated from birth to 12 weeks of age. Bull World Health Organ. 1985;63(6): 1151-1169
4. Taranger J, Trollfors B, Knutsson N, Sundh V, Lagergard T, Ostergaard E. Vaccination of infants with a four-dose and a three-dose vaccination schedule. Vaccine. 1999;18(9-10): 884-891
5. World Health Organization. Expanded programme on immunization. Global Advisory Group-Part I. Wkly Epidemiol Rec. 1992;67(3): 11-15
6. Vryheid RE, Kane MA, Muller N, Schatz GC, Bezabeh S. Infant and adolescent hepatitis B immunization up to 1999: a global overview. Vaccine. 2001;19(9-10):1026-1037
7. Viviani S, Jack A, Hall AJ, Maine N, Mendy M, Montesano R, et al. Hepatitis B vaccination in infancy in The Gambia: protection against carriage at 9 years of age. Vaccine. 1999; 17(23-24):2946-2950
8. World Health Organization. The Children's Vaccine Initiative and the Global Programme for Vaccines and Immunization. Recommendations from the Special Advisory Group of Experts. Part I. Wkly Epidemiol Rec. 1996; 71(35):261-266
9. World Health Organization. Global Programme for Vaccines and Immunization (GPV). The WHO position paper on Haemophilus influenzae type b conjugate vaccines. Wkly Epidemiol Rec. 1998;73(10):64-68
10. World Health Organization. Introducing Haemophilus influenzae type b conjugate vaccine into national immunization services. WHO Fact Sheet 2001. Geneva: WHO; 2001.
11. Peltola H, Aavitsland P, Hansen KG, Jonsdottir KE, Nokleby H, Romanus V. Perspective: a five-country analysis of the impact of four different Haemophilus influenzae type b conjugates and vaccination strategies in Scandinavia. J Infect Dis. 1999;179(1):223-229
12. Peltola H. Worldwide Haemophilus influenzae type b disease at the beginning of the 21st century: global analysis of the disease burden 25 years after the use of the polysaccharide vaccine and a decade after the advent of conjugates. Clin Microbiol Rev. 2000;13(2):302-317
13. United States Centers for Disease Control and Prevention. Progress toward eliminating Haemophilus influenzae type b disease among infants and children-United States, 1987- 1997. MMWR Morb Mortal Wkly Rep. 1998; 47(46):993-998
14. Trotter CL, McVernon J, Andrews NJ, Burrage M, Ramsay ME. Antibody to Haemophilus influenzae type b after routine and catch-up vaccination. Lancet. 2003;361(9368):1523-1524
15. Nascimento-Carvalho CM, de Andrade AL. Haemophilus influenzae type b vaccination: long-term protection. J Pediatr (Rio J). 2006; 82(3 suppl):109-114
16. United States Centers for Disease Control and Prevention. Combination vaccines for childhood immunization. MMWR Recomm Rep. 1999;48(RR-5):1-14.
17. Kanra G, Kara A, Demiralp O, Contorni M, Hilbert AK, Spyr C, et al. Safety and immunogenicity of a new fully liquid DTPw-HepBHib combination vaccine in infants. Hum Vaccin. 2006;2(4):155-160
18. Wiedenmayer K, Weiss S, Chattopadhyay C, Mukherjee A, Kundu R, Ayè R, et al. Simplifying paediatric immunization with a fully liquid DTP-HepB-Hib combination vaccine: Evidence from a comparative time-motion study in India. Vaccine. 2009;27:655-659
19. Mertsola J, Ruuskanen O, Kuronen T, Meurman O, Viljanen MK. Serologic diagnosis of pertussis: evaluation of pertussis toxin and other antigens in enzyme-linked immunosorbent assay. J Infect Dis. 1990;161:966-971
20. Mariani M, Luzzi E, Proietti D, Mancianti S, Casini D, Costantino P, et al. A competitive enzyme-linked immunosorbent assay for measuring the levels of serum antibody to Haemophilus influenzae type b. Clin Diagn Lab Immunol. 1998;5(5):667-674
21. Deinhardt F, Zuckerman AJ. Immunization against hepatitis B: report on a WHO meeting on viral hepatitis in Europe. J Med Virol. 1985; 17(3):209-217
22. Marcy SM, Kohl KS, Dagan R, Nalin D, Blum M, Jones MC, et al. Fever as an adverse event following immunization: case definition and guidelines of data collection, analysis, and presentation. Vaccine. 2004;22(5-6):551-556
23. Slack MH, Thwaites RJ, Schapira D, Crowley-Luke A, Southern J, Miller E, et al. Hib IgG persistence following early booster dose. Arch Dis Child. 2005;90(3):329.
24. Slack MH, Schapira D, Thwaites RJ, Burrage M, Southern J, Goldblatt D, et al. Responses to a fourth dose of Haemophilus influenzae type B conjugate vaccine in early life. Arch Dis Child Fetal Neonatal Ed. 2004;89(3):269-271
25. Halsey NA. Combination vaccines: defining and addressing current safety concerns. Clin Infect Dis. 2001;33(suppl 4):312-318
26. Faingezicht I, Avila-Aguerro ML, Cervantes Y, Fourneau M, Clemens SA. Primary and booster vaccination with DTPw-HB/Hib pentavalent vaccine in Costa Rican children who had received a birth dose of hepatitis B vaccine. Rev Panam Salud Publica. 2002;12(4): 247-257